Evidence map›Paper›PMID 33644277›Full record

ArticleJAAD case reports2021

Nivolumab-associated cutaneous T-cell lymphoma.

Jennifer A Marks, Douglas C Parker, L Crain Garrot, Mary Jo Lechowicz

Abstract readCase Reports
In one paragraph

Article in JAAD case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jennifer A MarksDepartment of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.
Douglas C ParkerDepartment of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
L Crain GarrotGeorgia Cancer Specialists, Northside Hospital Cancer Institute, Atlanta, Georgia.
Mary Jo LechowiczDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventsCTCLCTCL, cutaneous T-cell lymphomaimmune checkpoint inhibitormycosis fungoidesnivolumabRCC, renal cell carcinomaSezary syndrome

Identifiers

PMID33644277
PMCPMC7887609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.